Article (Scientific journals)
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
DARCIS, Gilles; Kula, Anna; Bouchat, Sophie et al.
2015In PLoS Pathogens, 11 (7), p. 1005063
Peer Reviewed verified by ORBi
 

Files


Full Text
Gatot Plos Pathog 2015.pdf
Publisher postprint (4.66 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] The persistence of latently infected cells in patients under combinatory antiretroviral therapy (cART) is a major hurdle to HIV-1 eradication. Strategies to purge these reservoirs are needed and activation of viral gene expression in latently infected cells is one promising strategy. Bromodomain and Extraterminal (BET) bromodomain inhibitors (BETi) are compounds able to reactivate latent proviruses in a positive transcription elongation factor b (P-TEFb)-dependent manner. In this study, we tested the reactivation potential of protein kinase C (PKC) agonists (prostratin, bryostatin-1 and ingenol-B), which are known to activate NF-kappaB signaling pathway as well as P-TEFb, used alone or in combination with P-TEFb-releasing agents (HMBA and BETi (JQ1, I-BET, I-BET151)). Using in vitro HIV-1 post-integration latency model cell lines of T-lymphoid and myeloid lineages, we demonstrated that PKC agonists and P-TEFb-releasing agents alone acted as potent latency-reversing agents (LRAs) and that their combinations led to synergistic activation of HIV-1 expression at the viral mRNA and protein levels. Mechanistically, combined treatments led to higher activations of P-TEFb and NF-kappaB than the corresponding individual drug treatments. Importantly, we observed in ex vivo cultures of CD8+-depleted PBMCs from 35 cART-treated HIV-1+ aviremic patients that the percentage of reactivated cultures following combinatory bryostatin-1+JQ1 treatment was identical to the percentage observed with anti-CD3+anti-CD28 antibodies positive control stimulation. Remarkably, in ex vivo cultures of resting CD4+ T cells isolated from 15 HIV-1+ cART-treated aviremic patients, the combinations bryostatin-1+JQ1 and ingenol-B+JQ1 released infectious viruses to levels similar to that obtained with the positive control stimulation. The potent effects of these two combination treatments were already detected 24 hours post-stimulation. These results constitute the first demonstration of LRA combinations exhibiting such a potent effect and represent a proof-of-concept for the co-administration of two different types of LRAs as a potential strategy to reduce the size of the latent HIV-1 reservoirs.
Disciplines :
Genetics & genetic processes
Author, co-author :
DARCIS, Gilles ;  Centre Hospitalier Universitaire de Liège - CHU
Kula, Anna
Bouchat, Sophie
Fujinaga, Koh
Corazza, Francis
Ait-Ammar, Amina
Delacourt, Nadege
Melard, Adeline
Kabeya, Kabamba
Vanhulle, Caroline
Van Driessche, Benoit
GATOT, Jean-Stéphane ;  Centre Hospitalier Universitaire de Liège - CHU > Génétique
Cherrier, Thomas
Pianowski, Luiz F.
Gama, Lucio
Schwartz, Christian
Vila, Jorge
Burny, Arsène ;  Université de Liège - ULiège > Agro Biotech Gembloux
Clumeck, Nathan
Moutschen, Michel  ;  Université de Liège > Département des sciences cliniques > GIGA-R:Immunopath. - Maladies infect. et médec. inter. gén.
De Wit, Stephane
Peterlin, B. Matija
Rouzioux, Christine
Rohr, Olivier
Van Lint, Carine
More authors (15 more) Less
Language :
English
Title :
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene Expression.
Publication date :
2015
Journal title :
PLoS Pathogens
ISSN :
1553-7366
eISSN :
1553-7374
Publisher :
Public Library of Science, United States - California
Volume :
11
Issue :
7
Pages :
e1005063
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 13 September 2015

Statistics


Number of views
118 (4 by ULiège)
Number of downloads
138 (1 by ULiège)

Scopus citations®
 
211
Scopus citations®
without self-citations
174
OpenCitations
 
214

Bibliography


Similar publications



Contact ORBi